Noah Holdings (NASDAQ:NOAH) released its earnings data on Monday. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.04, AnalystRatings.NET reports. The company had revenue of $50.30 million for the quarter, compared to the consensus estimate of $49.93 million. Noah Holdings Limited (ADR) (NYSE:NOAH) net profit margin is 31.10% and weekly performance is 1.16%. On last trading day company shares ended up $13.99. Analysts mean target price for the company is $22.99. Noah Holdings Limited (ADR) (NYSE:NOAH) distance from 50-day simple moving average (SMA50) is -4.10%.
Arena Pharmaceuticals logo Arena Pharmaceuticals (NASDAQ:ARNA) announced its earnings results on Monday. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by $0.02, Analyst RN reports. The company had revenue of $6.80 million for the quarter, compared to the consensus estimate of $7.98 million. During the same quarter in the previous year, the company posted ($0.09) earnings per share. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares fell -4.87% in last trading session and ended the day on $6.84. ARNA gross Margin is 92.40% and its return on assets is -6.80%.Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) quarterly performance is 6.38%.
Halozyme Therapeutics Inc. (NASDAQ:HALO) reported a first quarter net loss of $0.22 per share after the close Monday, compared to the loss of $0.17 per share last year. Halozyme Therapeutics, Inc. (NASDAQ:HALO) shares moved up 2.04% in last trading session and was closed at $7.52, while trading in range of $7.26 – $7.56. Halozyme Therapeutics, Inc. (NASDAQ:HALO) year to date (YTD) performance is -49.83%.
Portola Pharmaceuticals Inc. (NASDAQ:PTLA) reported a net loss of $30.7 million, or $0.75 net loss per share, for the first quarter of 2014, compared with a net loss of $18.1 million, or $12.94 net loss per share, for the first quarter of 2013. Shares used to compute net loss per share attributable to common stockholders were approximately 41.0 million for the first quarter of 2014, compared with approximately 1.4 million for the same period in 2013. Portola Pharmaceuticals Inc. (NASDAQ:PTLA) ended the last trading day at $23.95. Company weekly volatility is calculated as 4.97% and price to cash ratio as 3.66.Portola Pharmaceuticals Inc. (NASDAQ:PTLA) showed a positive weekly performance of 0.13%.
Ambac Financial Group (NASDAQ:AMBC) announced its earnings results on Monday. The company reported $3.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.01 by $2.30, AmericanBankingNews.com reports. During the same quarter in the previous year, the company posted $0.98 earnings per share. Ambac Financial Group, Inc. (NASDAQ:AMBC) ended the last trading day at $29.91. Company weekly volatility is calculated as 3.55% and price to cash ratio as 17.39.Ambac Financial Group, Inc. (NASDAQ:AMBC) showed a positive weekly performance of 0.40%.